ZA802909B - Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics - Google Patents

Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics

Info

Publication number
ZA802909B
ZA802909B ZA00802909A ZA802909A ZA802909B ZA 802909 B ZA802909 B ZA 802909B ZA 00802909 A ZA00802909 A ZA 00802909A ZA 802909 A ZA802909 A ZA 802909A ZA 802909 B ZA802909 B ZA 802909B
Authority
ZA
South Africa
Prior art keywords
compounds
therapeutics
processes
preparation
pharmaceutical preparations
Prior art date
Application number
ZA00802909A
Other languages
English (en)
Inventor
A Marxer
K Eichenberger
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA802909B publication Critical patent/ZA802909B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00802909A 1979-05-18 1980-05-16 Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics ZA802909B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466979 1979-05-18

Publications (1)

Publication Number Publication Date
ZA802909B true ZA802909B (en) 1981-05-27

Family

ID=4280399

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00802909A ZA802909B (en) 1979-05-18 1980-05-16 Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics

Country Status (21)

Country Link
EP (1) EP0019811A1 (fr)
JP (1) JPS55154971A (fr)
KR (1) KR830002757A (fr)
AR (1) AR228256A1 (fr)
AU (1) AU5848480A (fr)
DD (1) DD150609A5 (fr)
DK (1) DK214480A (fr)
ES (1) ES491514A0 (fr)
FI (1) FI801600A (fr)
GB (1) GB2052487B (fr)
GR (1) GR68453B (fr)
IE (1) IE49803B1 (fr)
IL (1) IL60086A (fr)
MA (1) MA18829A1 (fr)
NO (1) NO801469L (fr)
NZ (1) NZ193730A (fr)
OA (1) OA06533A (fr)
PL (1) PL224313A1 (fr)
PT (1) PT71251A (fr)
ZA (1) ZA802909B (fr)
ZW (1) ZW11880A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507146A (en) * 1982-12-28 1985-03-26 Ciba-Geigy Corporation 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity
DE3829469A1 (de) * 1988-08-31 1990-03-01 Bayer Ag Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung
WO1999011269A1 (fr) * 1997-09-03 1999-03-11 Eli Lilly And Company Derives de pyrimidine
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
EP1318997B1 (fr) 2000-09-15 2006-05-31 Vertex Pharmaceuticals Incorporated Composes pyrazole utiles en tant qu'inhibiteurs de proteine kinase
IL156368A0 (en) 2000-12-21 2004-01-04 Vertex Pharma Pyrazole derivatives and pharmaceutical compositions containing the same
BR0206844A (pt) * 2001-01-31 2005-07-12 Synaptic Pharma Corp Uso de antagonistas do receptor gal3 para o tratamento de depressão e/ou ansiedade e compostos usados em tais métodos
CA2479036A1 (fr) 2002-03-13 2003-09-18 Euro-Celtique S.A. Pyrimidines substituees par aryle et utilisation associee
WO2003078427A1 (fr) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines inhibitrices des proteines kinases
AU2003214110A1 (en) * 2002-03-15 2003-09-29 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
WO2004013140A1 (fr) 2002-08-02 2004-02-12 Vertex Pharmaceuticals Incorporated Compositions pyrazole convenant comme inhibiteurs de gsk-3
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
WO2007022384A2 (fr) 2005-08-18 2007-02-22 Vertex Pharmaceuticals Incorporated Inhibiteurs de pyrazine kinases
SG166828A1 (en) 2005-11-03 2010-12-29 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
AU2007317435A1 (en) 2006-11-02 2008-05-15 Vertex Pharmaceuticals Incorporated Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
DE602007007985D1 (de) 2006-12-19 2010-09-02 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyrimidine
ES2435997T3 (es) 2007-03-09 2013-12-26 Vertex Pharmaceuticals, Inc. Aminopirimidinas útiles como inhibidores de las proteínas cinasas
RU2009137390A (ru) 2007-03-09 2011-04-20 Вертекс Фармасьютикалз Инкорпорейтед (Us) Аминопиримидины, пригодные в качестве ингибиторов протеинкиназ
JP2010520887A (ja) 2007-03-09 2010-06-17 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリジン
AU2008240313A1 (en) 2007-04-13 2008-10-23 Aj Park Aminopyrimidines useful as kinase inhibitors
MX2009011812A (es) 2007-05-02 2010-01-14 Vertex Pharma Aminopirimidinas utiles como inhibidores de cinasa.
EP2152694A2 (fr) 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles et pyrazoles qui s'utilisent comme inhibiteurs de kinase
EP2176261B1 (fr) 2007-07-31 2012-12-19 Vertex Pharmaceuticals Incorporated Procédé de préparation de la 5-fluoro-1h-pyrazolo [3,4-b] pyridin-3-amine et des dérivés de celle-ci
WO2010027921A1 (fr) 2008-09-03 2010-03-11 Vertex Pharmaceuticals Incorporated Co-cristaux et formulations pharmaceutiques les comprenant
ES2467108T3 (es) * 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
KR102328682B1 (ko) * 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines

Also Published As

Publication number Publication date
DD150609A5 (de) 1981-09-09
EP0019811A1 (fr) 1980-12-10
FI801600A (fi) 1980-11-19
IE49803B1 (en) 1985-12-25
IL60086A (en) 1984-03-30
GB2052487B (en) 1983-05-11
GR68453B (fr) 1981-12-30
AU5848480A (en) 1980-11-20
PT71251A (en) 1980-06-01
IL60086A0 (en) 1980-07-31
IE801023L (en) 1980-11-18
PL224313A1 (fr) 1981-02-13
MA18829A1 (fr) 1980-12-31
JPS55154971A (en) 1980-12-02
ES8104279A1 (es) 1981-04-16
GB2052487A (en) 1981-01-28
DK214480A (da) 1980-11-19
OA06533A (fr) 1981-07-31
NZ193730A (en) 1982-12-21
ZW11880A1 (en) 1980-12-17
KR830002757A (ko) 1983-05-30
AR228256A1 (es) 1983-02-15
NO801469L (no) 1980-11-19
ES491514A0 (es) 1981-04-16

Similar Documents

Publication Publication Date Title
ZA802909B (en) Pyrimidine compounds, processes for their preparation, pharmaceutical preparations containing these compounds, and their use in therapeutics
DE3067252D1 (en) Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use
MY8500051A (en) Novel 1-aryl-2-acylamido-3-fluoro-1-propanols, theiri preparation and pharmaceutical composition containing them
IL63913A0 (en) Pyrimidone derivatives,process for their preparation,pharmaceutical compositions containing them and their use
DE3062310D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
PH16228A (en) Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use
DE3262536D1 (en) N-dihydrothiazolyl-3-quinoleine carboxyamide derivatives, their salts, their preparation and use as pharmaceutical preparations, and pharmaceutical preparations containing them
ZA821957B (en) Acylquinolinone derivatives, processes for their manufacture, pharmaceutical preparations containing them and their use
IL59665A0 (en) Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
GB2060633B (en) Isocyanuric acid derivatives preparation and pharmaceutical use thereof
IL59410A0 (en) Pyrazole derivatives,pharmaceutical formulations containing these derivatives and processes for their preparation
DE2966413D1 (en) Pyrimidinone derivatives, processes for preparing them and pharmaceutical compositions containing them
DE3062268D1 (en) Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
IL60325A0 (en) Novel quinazoline derivatives and pharmaceutical preparations containing them
IL61240A0 (en) Quinazoline derivatives, their preparation and pharmaceutical compositions containing them
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
ZA812034B (en) Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use
CY1263A (en) Glucofuranos-6-yl-nitroso urea derivatives,processes for their preparation and their use in pharmaceutical compositions
IL59664A0 (en) Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
DE3168978D1 (en) Thiazoline derivatives, their preparation and use and pharmaceutical preparations containing them
DE2862102D1 (en) Pyrimido (4,5-c) pyridazines, their use in pharmaceutical preparations, and process for their preparation
ZA793336B (en) Novel phenylpiperidine derivatives,processes for their preparation,pharmaceutical preparations containing these derivatives and their use
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
ZW15180A1 (en) Aminothiadiazolyl compounds processes for the manufacture thereof and pharmaceutical preparations containing such compounds and the use thereof
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines